Does Stevia Raise Blood Glucose?

Does stevia raise blood glucose? This is a common question among people managing diabetes or looking to reduce their sugar intake. Stevia is a plant-derived, non-nutritive sweetener extracted from Stevia rebaudiana and approved for use in the UK as food additive E960. Unlike sugar, its active compounds, steviol glycosides, are not metabolised as carbohydrates and do not trigger a significant glycaemic response. This article examines the current evidence on stevia and blood glucose, its effect on insulin, and practical guidance for incorporating it into a balanced UK diet.

Does stevia raise blood glucose levels?

Stevia does not raise blood glucose levels in the way sugar does. Its active compounds, steviol glycosides, are not metabolised as carbohydrates and produce a negligible glycaemic response at typical dietary amounts.

Stevia does not raise blood glucose levels in the way that sugar does, and current evidence suggests it has a negligible effect on blood glucose when consumed in typical dietary amounts. Stevia is a plant-derived, non-nutritive sweetener extracted from the leaves of Stevia rebaudiana. Its active compounds, known as steviol glycosides, are intensely sweet but are not metabolised in the same way as carbohydrates, meaning they contribute no meaningful calories and do not trigger the same glycaemic response as sucrose or glucose.

The sweetener has been approved for use in food and beverages across the European Union and the United Kingdom, where it is regulated as a food additive under the designation E960. The UK Food Standards Agency (FSA) considers steviol glycosides safe for the general population when consumed within acceptable daily intake (ADI) levels.^[2][3] The ADI is set at 4 mg per kilogram of body weight per day, expressed as steviol equivalents. This figure is derived from the EFSA scientific opinion on the safety of steviol glycosides (EFSA 2010, updated 2015), which the FSA applies in Great Britain under retained food law.^[1]

It is worth noting that the calorie contribution of stevia itself is negligible, but many retail stevia products include bulking agents such as maltodextrin, dextrose or erythritol to improve texture and pourability. These additives can contribute carbohydrate and energy, so the label of the specific product matters. Reading the full nutritional label remains essential for anyone monitoring their blood sugar levels.

For people managing type 2 diabetes or prediabetes, the non-glycaemic nature of steviol glycosides makes stevia an attractive alternative to sugar. However, the overall glycaemic impact of a food or drink depends on all its ingredients, not just the sweetener used. A product labelled as containing stevia may still contain other carbohydrates, starches or syrups that can raise blood glucose.

What the current evidence says about stevia and diabetes

Clinical trials broadly show stevia does not adversely affect blood glucose control in type 2 diabetes, and some studies suggest modest reductions in fasting glucose and HbA1c, though evidence remains limited by small study sizes.

Clinical research broadly supports the view that stevia does not adversely affect blood glucose control in people with type 2 diabetes, and some studies suggest it may offer modest benefits. A number of small randomised controlled trials have found that consuming stevia before or with a meal does not produce a significant rise in postprandial blood glucose compared with a no-sweetener control, and in some cases produces a lower glucose response than sucrose. These findings are consistent with the mechanistic expectation that steviol glycosides are not absorbed as carbohydrates.

A review published in the journal Nutrients (Ashwell et al., 2020) examined multiple human studies and concluded that steviol glycosides were associated with reductions in fasting blood glucose and HbA1c in people with type 2 diabetes. The authors noted that study sizes were generally small, follow-up periods short, and methodologies varied considerably, so the findings should be interpreted with caution. Larger, longer-term trials are needed before firm conclusions can be drawn about the magnitude of any benefit.

NICE guidance on type 2 diabetes management (NG28) encourages dietary approaches that reduce free sugar intake as part of an overall healthy eating pattern.^[4] Non-nutritive sweeteners such as stevia can form part of a strategy to reduce overall sugar consumption. NICE does not specifically endorse any single sweetener, and the broader dietary pattern, including total carbohydrate quality and quantity, remains the priority. Diabetes UK similarly notes that low-calorie sweeteners can be a useful tool for reducing sugar intake, but emphasises that they should be used as part of a balanced diet rather than as a standalone solution.

It is also worth noting that individual responses to sweeteners can vary. Some research has explored whether non-nutritive sweeteners influence gut microbiota composition, which in turn may affect metabolic responses, though evidence in this area remains preliminary and inconclusive.^[11] People with diabetes who wish to incorporate stevia into their diet are encouraged to discuss this with their GP or diabetes care team.

Practical tips for using stevia as part of a balanced UK diet

Check the full nutritional label on stevia products, as bulking agents such as maltodextrin or dextrose can still raise blood glucose. Use stevia to replace sugar rather than adding it to an already sweet diet.

Stevia can be incorporated into a balanced UK diet as a practical way to reduce free sugar intake without significantly affecting blood glucose levels, provided it is used thoughtfully alongside an overall healthy eating pattern. It is available in several forms in UK supermarkets and health food shops, including liquid drops, granulated blends, and tablet form.

Many tabletop stevia products blend steviol glycosides with bulking agents such as maltodextrin or dextrose, which do contribute carbohydrate and calories. Erythritol is another common bulking agent; it has a much lower glycaemic impact than maltodextrin or dextrose but is still worth noting on the label. When checking a product, look at the "carbohydrates, of which sugars" row on the nutrition panel as well as the ingredients list.

When baking or cooking, stevia behaves differently from sugar. It does not caramelise or provide the same bulk, so recipes may need adjustment. Many manufacturers provide conversion guides, as stevia is considerably sweeter than sugar by weight. Using a stevia blend specifically formulated for baking can help achieve better results.

For people managing blood glucose, the following practical points are worth keeping in mind:

• Check the full nutritional label on any stevia-sweetened product, including the carbohydrate content, as bulking agents such as maltodextrin or dextrose may still contribute to blood glucose rises.

• Use stevia to replace, not add to, sweet foods. Substituting sugar with stevia in tea, coffee or yoghurt is more beneficial than simply adding it to an already sweet diet.

• Be cautious with processed foods marketed as "no added sugar" or "sweetened with stevia," as these may still be high in refined carbohydrates.

• Stevia-sweetened products are not suitable for treating hypoglycaemia, as they contain little or no available carbohydrate. Always use an appropriate fast-acting carbohydrate source (such as glucose tablets or a sugary drink) to treat a hypo.

• Maintain a varied, balanced diet in line with NHS Eatwell Guide principles, which emphasise vegetables, wholegrains, lean proteins and healthy fats.

If you have diabetes or are at risk of developing it, your GP or a registered dietitian can offer personalised guidance on sweetener use within your overall dietary plan.

How does stevia affect insulin and blood sugar response?

Stevia has minimal effect on insulin secretion as steviol glycosides bypass carbohydrate-driven absorption. It does not cause hypoglycaemia and is not suitable as a treatment for low blood glucose.

Stevia appears to have a minimal effect on insulin secretion in healthy individuals, and some research suggests it may support a more favourable insulin response compared with sugar. Steviol glycosides are not absorbed in the small intestine in the same way as sugars. Instead, they pass largely intact to the large intestine, where gut bacteria convert them into steviol. Steviol is then absorbed, undergoes glucuronidation in the liver, and is excreted in the urine as steviol glucuronide. This metabolic pathway, described in the EFSA scientific opinion on steviol glycosides, means stevia does not stimulate significant insulin release through the usual carbohydrate-driven mechanism.

Some laboratory and small human studies have suggested that certain steviol glycosides, particularly stevioside and rebaudioside A, may have a direct effect on pancreatic beta cells, potentially enhancing insulin secretion in a glucose-dependent manner. This means any effect on insulin release would only occur when blood glucose is already elevated, which is a theoretically desirable property for people with type 2 diabetes. However, these findings come largely from in vitro and animal studies, and their clinical relevance in humans has not been established. They should not be taken as evidence of a therapeutic effect.

Stevia does not appear to cause hypoglycaemia (abnormally low blood glucose) in people without diabetes, and there is no established evidence that it causes problematic insulin spikes. As noted above, stevia-sweetened products are not suitable for treating hypoglycaemia because they provide little or no available carbohydrate.

For people taking insulin or glucose-lowering medications such as sulfonylureas, it is still advisable to monitor blood glucose regularly and discuss any significant dietary changes with a healthcare professional, as overall carbohydrate intake and meal composition will have a greater influence on blood sugar than the choice of sweetener alone.

If you experience unexpected changes in blood glucose readings after dietary changes, contact your GP for advice rather than adjusting medication independently.

Scientific References

1. Scientific Opinion on the safety of steviol glycosides for the proposed uses as a food additive.
2. Approved additives and E numbers.
3. The truth about sweeteners.
4. Type 2 diabetes in adults: management (NG28).
5. Pharmacokinetics of Oral Rebaudioside A in Patients with Type 2 Diabetes Mellitus and Its Effects on Glucose Homeostasis: A Placebo-Controlled Crossover Trial.
6. Rebaudioside A directly stimulates insulin secretion from pancreatic beta cells: a glucose-dependent action via inhibition of ATP-sensitive K-channels.
7. Stevioside acts directly on pancreatic beta cells to secrete insulin.
8. Joint position statement on the use of low or no calorie sweeteners (LNCS).
9. Diabetes — Type 2.
10. SACN statement on the WHO guideline on non-sugar sweeteners — summary.

Frequently Asked Questions